HANY ASHAMALLA: Open Payments
NPI 1255645891 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 24 payments from 10 companies in 2025. Trend: 2023 $272 · 2024 $302 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 5 | $138 |
| Alkermes, Inc. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: REXULTI, ARISTADA, CAPLYTA, INGREZZA, COBENFY, FANAPT, TRINTELLIX, INVEGA SUSTENNA.
Industry payments across AZ — which companies pay providers there.
